[
Halozyme Therapeutics director Matthew Posard sells $482,146 in stock
[og_img]
https://www.investing.com/news/insider-trading-news/halozyme-therapeutics-director-matthew-posard-sells-482146-in-stock-93CH-5037392
Investing.com
Halozyme Therapeutics director Matthew Posard sells $482,146 in stock
Related articles




